Evidence map›Paper›PMID 40258842›Full record

ArticleScientific reports2025

Comparison of phage and plasmid populations in the gut microbiota between Parkinson's disease patients and controls.

Ilhan Cem Duru, Alexandre Lecomte, Pia Laine, Tânia Keiko Shishido, Joni Suppula, Lars Paulin, Filip Scheperjans, Pedro A B Pereira, Petri Auvinen

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ilhan Cem DuruInstitute of Biotechnology, University of Helsinki, Helsinki, Finland. ilhan.duru@helsinki.fi.
Alexandre LecomteInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Pia LaineInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Tânia Keiko ShishidoInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Joni SuppulaInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Lars PaulinInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Filip ScheperjansDepartment of Neurology, Helsinki University Hospital and Clinicum, University of Helsinki, Helsinki, Finland.
Pedro A B Pereira *Institute of Biotechnology, University of Helsinki, Helsinki, Finland. pedro.pereira@helsinki.fi.
Petri Auvinen *Institute of Biotechnology, University of Helsinki, Helsinki, Finland.

Funding

Novo Nordisk Foundation NNF22OC0080109
6 · The paper itself

Abstract

The aging population worldwide is on the rise, leading to a higher number of Parkinson's disease (PD) cases each year. PD is presently the second most prevalent neurodegenerative disease, affecting an estimated 7-10 million individuals globally. This research aimed to identify mobile genetic elements in human fecal samples using a shotgun metagenomics approach. We identified over 44,000 plasmid contigs and compared plasmid populations between PD patients (n = 68) and controls (n = 68). Significant associations emerged between groups (control vs PD) based on plasmid alpha and beta diversity. Moreover, the gene populations present on plasmids displayed marked differences in alpha and beta diversity between PD patients and controls. We identified a considerable number of phage contigs that were differentially abundant in the two groups. We also developed a predictive machine learning model based on phage abundance data, achieving a mean Area Under the Curve (AUC) of 0.74 with a standard deviation of 0.105 and a mean F1 score of 0.68 with a standard deviation of 0.14 across cross-validation folds, indicating moderate discriminatory power. Additionally, when tested on external data, the model yielded an AUC of 0.74 and an F1 score of 0.8, further demonstrating the predictive potential of phage populations in Parkinson's disease. Further, we improved the continuity and identification of the protein coding regions of the phage contigs by implementing alternative genetic codes.

Indexed as

BacteriophagesGastrointestinal MicrobiomeParkinson DiseasePlasmidsAgedCase-Control StudiesFecesFemaleHumansMachine LearningMaleMetagenomicsMiddle AgedGut microbiotaMobile genetic elementsParkinson’s disease

Identifiers

PMID40258842
PMCPMC12012184

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.